CD8A and neoplasm: In another approach, it was demonstrated that immunization with vaccinia virus (VV)-ovalbumin (OVA) followed by administration of SFV-OVA or vice versa enhanced OVA-specific CD8+ T cell immune responses in tumor bearing mice [91].